Requests similar to 'Differences between BNT162b2 and Comirnaty®' (page 6)
Informed Consent #24 - Missing Information in Risk Management Plan for Comirnaty
Response by Andrew Little to Annie Weston on .
Refused.
Kia ora Annie
Please find a request from the Ministry of Health to rescope your
consolidated requests.
Ngā mihi
OIA Services
Office...
Informed Consent #29 - When did the PM receive the post-marketing info from Pfizer
Response by Department of the Prime Minister and Cabinet to Annie Weston on .
Refused.
Kia ora Annie
Please find a request from the Ministry of Health to rescope your
consolidated requests.
Ngā mihi
OIA Services
Office...
Kia ora Jai
Please find attached a letter regarding your request for information.
Ngā mihi
OIA Services
Government Services
Office of the Direc...
Kia ora J Bruning
Please find attached a letter regarding your request for
information. Under section 28(3) of the Act you have the right to as...
Estimated timeline and details on public availability of Novavax
Response by Ministry of Health to Mr Massey on .
Successful.
Kia ora Mr Massey,
Please see attached the response to your OIA request.
Ngā mihi
OIA Services Team
[1]Ministry of Health...
VACCINE PROTECTION DEFINITION, How do you define someone as fully vaccinated?
Response by Ministry of Health to Kiwi on .
Awaiting classification.
Kia ora Kiwi,
Thank you for your email.
In relation to New Zealand's COVID-19 vaccination programme, using the
Pfizer vaccine,
the Ministry con...
Pandemic Vaccine Procurement, India FTA Implications, and Advance Purchase Agreement Framework
Response by Pharmaceutical Management Agency to Penny Claridge on .
Partially successful.
Kia ora Penny,
Please find attached a response to your request for official information.
Ngā mihi,
Government Services | Pharmac...
Process and progress of approval for pediatric/under 5’s covid vaccines
Response by Pharmaceutical Management Agency to Scout Barbour-Evans on .
Partially successful.
Kia ora Scout
Please find attached a response to your request for official information.
Ngā mihi
OIA Services Team
M[1]inistry of Health...
Please explain the meaning of the Latest Regulatory Activity
Response by Ministry of Health to Virginia Crawford on .
Long overdue.
Dear Virginia
In answer to your OIA request, I have been asked to respond directly.
In New Zealand Pre-marketing approval must be obtained for new an...
Whistleblower Protection(s) Afforded to Barry Young
Follow up sent to Ministry of Justice by Chris McCashin on .
Awaiting classification.
Can you please urgently respond to this and / or take the vaccine off the shelves until we can get some answers from our agencies.
As at todays da...
Informed Consent #21 - Gene Therapy
Long overdue.
There is a case in the US saying The Covid 19 vaccination is not a vaccine rather it is gene therapy:
In fact, the CDC has actually changed its defin...
Please make other vaccines available
Response by Ministry of Health to mariya nilan on .
Awaiting classification.
Kia ora Mariya,
Thank you for your email.
Before a COVID-19 vaccine can be used in New Zealand, Cabinet must agree
on a ‘decision to use’....
Kia ora Tracy,
Please find attached a response to your request for information.
Ngā mihi
OIA Services Team
Manatū Hauora | Ministry of Hea...
Quantity of comirnaty doses purchased for nz now and in the future
Response by Ministry of Health to Erika Whittome on .
Reported for administrator attention.
Kia ora Erika
Please see attached a letter regarding your request for official
information.
Ngā mihi
OIA Services Team
Manatū Hauora | Mi...
Changes to the licensing of pharmacies in New Zealand
Response by Minister of Health to WGRH on .
Successful.
Dear WG Robert Harrison
Please find attached a letter regarding your request for official
information.
Kind regards,
Samantha Irons l OIA Co-ord...
Kia ora Mary,
Thank you for your query regarding the Novavax vaccine. This vaccine is
not currently approved for use in New Zealand.
Medsa...
Regulatory Assessment Processes involved in assessing the Covid-19 Pfizer Contract
Response by Ministry of Health to Nadine Connock on .
Refused.
Kia ora,
Thank you for your request for official information received on 5 August
2025 for:
“
Thank you for your response detailing the...
Independent Monitoring Safety Board
Response by Ministry of Health to Chuck Schooner (Account suspended) on .
Awaiting classification.
Kia ora,
Please find attached a response to your official information act request
Ngā mihi
OIA Services
Government Services
Offi...
Pilot program for covid-19 vaccination in the workplace
Response by Ministry of Health to Doris Burke on .
Awaiting classification.
Kia ora Doris,
Please now find attached our response to your request. Again, we sincerely
apologise for the delay.
If you have any questions,...
Request for documents received by Minister for COVID-19 Response
Response by Chris Hipkins to Ashleigh Fechney on .
Partially successful.
Kia ora Ashleigh,
Please find attached the Ministers response to your request for official information.
Ngâ mihi,
Daniel Martin
Health Private Secr...
Hospital Use of the Terms “Biologics/Biogenic Agents” and Consent Requirements for Vaccines and Injectable Products
Response by Ministry of Health to SPENCER JONES on .
Partially successful.
Kia ora Spencer
Thank you for your request under the Official Information Act 1982 (the
Act), received by the Ministry of Health on 23 November...
Fees paid to Medsafe by Pharmaceutical Industry
Response by Ministry of Health to Tracy Livingston on .
Partially successful.
Kia ora Tracy
Please find attached a response to your request for information
Ngā mihi
Ngā mihi
OIA Services Team
[1]Minist...
Medsafe Inconsistency
Response by Ministry of Health to Chuck Schooner (Account suspended) on .
Awaiting classification.
Kia ora,
Please find the attached that was sent to you 6 April 2022 at 2:15pm.
Ngā mihi
OIA Services Team
[1]Ministry of Health informat...
COVID Vaccines Supplied, Dispatched or Administered per Manufacturer and Health NZ Batch – Jan 2025 update
Request sent to Health New Zealand by Chris Johnston on .
Successful.
INTRODUCTION AND CONTEXT
This is a follow up to a previous OIA - HNZ00041853 . Please note that there are changes in the language in this OIA compar...
Kia ora,
Thank you for your email. Requests for information regarding spike
proteins has been previously responded to. Please find a previous respons...